Davis Polk advised on 13 matters recognized by Turnarounds & Workouts as “Successful Restructurings of 2024.”The highlighted matters include:AlkegenDigicelEyeCare…
Davis Polk advised on multiple matters that were recognized at the 19th Annual M&A Advisor Turnaround Awards. The awards honor the year’s leading distressed M&A, restructuring and…
On October 31, 2024, Davis Polk partners James Lin and Steve Wang will be among the speakers at the annual BioCentury-BayHelix China Healthcare Summit. The summit aims to help executives…
Davis Polk advised Galderma Group AG on its $2.6 billion initial public offering, which was named “Deal of the Year” at the 2024 LegalcommunityCH Awards. The awards recognize…
A Davis Polk team led by partners Jim Rouhandeh, head of the firm’s Litigation Department, and Neal Potischman, head of the firm’s West Coast commercial litigation practice, received runner…
Davis Polk advised on 16 matters recognized by Turnarounds & Workouts as “Successful Restructurings of 2023.”The highlighted matters include:Air MethodsAvayaAzulCineworld GroupCyxtera…
Davis Polk advised on multiple matters that were recognized at the 18th Annual M&A Advisor Turnaround Awards. The awards honor the year’s leading distressed M&A,…
On November 2, 2023, Davis Polk partners James Lin and Steve Wang will be among the speakers at the 10th annual BioCentury-BayHelix China Healthcare Summit. James and Steve will speak…
Davis Polk partner Jesse Solomon was quoted in the Capitol Forum on DOJ’s new self-disclosure safe harbor policy and its potential impact on health care M&A. Under the policy, federal…
Law360 has named four Davis Polk partners as 2023 MVPs:Margaret Tahyar – BankingJennifer Conway – BenefitsDavid Bauer – Life SciencesMarc Williams – Private EquityThe awards showcase…